Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02005289
Brief Title: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

First Submitted : December 3, 2013
First Submitted that Met QC Criteria : December 3, 2013
First Posted : December 9, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 25, 2019
Last Update Posted : March 26, 2019